Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1

Liver Transplantation

Volumn 17, Issue 11, 2011, Pages 1328-1332

  Boyer, Thomas D ^a   Sanyal, Arun J ^b   Garcia Tsao, Guadalupe ^c,d   Regenstein, Frederick ^e   Rossaro, Lorenzo ^f   Appenrodt, Beate ^g   Gülberg, Veit ^h,i   Sigal, Samuel ^j   Bexon, Alice S ^k   Teuber, Peter ^k  

^a UNIVERSITY OF ARIZONA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF BONN   (Germany)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ Liver Center Munich   (Germany)

^j NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^k Orphan Therapeutics   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; TERLIPRESSIN;

ADULT; ARTICLE; DISEASE ASSOCIATION; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL;

ALBUMINS; COHORT STUDIES; HEPATORENAL SYNDROME; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LYPRESSIN; PROGNOSIS; SURVIVAL RATE; VASOCONSTRICTOR AGENTS;

EID: 82955197324     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22395     Document Type: Article

References (21)

1. Arroyo V, Terra C, Ginès P. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol 2007;46:935-946. (Pubitemid 46529046)
2. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005;41:1282-1289. (Pubitemid 40770280)
3. Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-236. (Pubitemid 23234041)
4. Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, et al.; for Terlipressin Study Group. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008;134:1360-1368. (Pubitemid 351615358)
5. Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, et al.; for TAHRS Investigators. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008;134:1352-1359. (Pubitemid 351626950)
6. Neri S, Pulvirenti D, Malaguarnera M, Cosimo BM, Ber-tino G, Ignaccolo L, et al. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig Dis Sci 2008;53:830-835. (Pubitemid 351317073)
7. Gluud LL, Christensen K, Christensen E, Krag A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 2010;51: 576-584.
8. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 2008;48:2064-2077.
9. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313. (Pubitemid 40179517)
10. Rimola A, Gavaler JS, Schade RR, el-Lankany S, Starzl TE, Van Thiel DH. Effects of renal impairment on liver transplantation. Gastroenterology 1987;93:148-156. (Pubitemid 17084107)
11. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995;59:361-365.
12. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1185. (Pubitemid 34454015)
13. Moreau R. The growing evidence that renal function should be improved in patients with cirrhosis and hepa-torenal syndrome before liver transplantation. J Hepatol 2004;40:159-161. (Pubitemid 38064726)
14. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164-176. (Pubitemid 26012105)
15. Ginès P, Guevara M, Arroyo V, Rodés J. Hepatorenal syndrome. Lancet 2003;362:1819-1827. (Pubitemid 37494763)
16. Restuccia T, Ortega R, Guevara M, Ginès P, Alessandria C, Ozdogan O, et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol 2004;40:140-146. (Pubitemid 38064723)
17. Xu X, Ling Q, Zhang M, Gao F, He Z, You J, Zheng S. Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience. Transplantation 2009;87:1514-1519.
18. Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klint-malm GB. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome - experience in 300 patients. Transplantation 1991;51:428-430.
19. Ruiz R, Kunitake H, Wilkinson AH, Danovitch GM, Farmer DG, Ghobrial RM, et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 2006;141:735-741. (Pubitemid 44268509)
20. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008;8:2243-2251.
21. Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS. Renal outcomes after liver transplantation in the Model for End-Stage Liver Disease era. Liver Transpl 2009;15:1142-1148.